← back to search

Ping Lin

Harbin Medical University · CN
Area of research
Computational Mechanics · Inorganic Chemistry
Research interest
Research focused on Prostate cancer and Cancer research, with related work in Competing endogenous RNA, DU145, Gene knockdown. Notable publications include 'OCT4B modulates OCT4A expression as ceRNA in tumor cells', 'The CUL7/F-box and WD Repeat Domain Containing 8 (CUL7/Fbxw8) Ubiquitin Ligase Promotes Degradation of Hematopoietic Progenitor Kinase 1', and 'MicroRNA-124 regulates TGF-α-induced epithelial-mesenchymal transition in human prostate cancer cells'.
h-index
citations
389
works
16
NIH funding
primary concept
email

Recent publications

Long non-coding RNA AC245100.4 activates the PI3K/AKT pathway to promote PCa cell proliferation by elevating PAR2
Heliyon 2023cited by 2position: middledoi
Apaf‐1 interacting protein, a new target of microRNA‐146a‐3p, promotes prostate cancer cell development via the ERK1/2 pathway
Cell Biology International 2022cited by 23position: middledoi
Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway
Medical Oncology 2022cited by 23position: middledoi
GDI2 is a target of paclitaxel that affects tumorigenesis of prostate cancer via the p75NTR signaling pathway
Biochemical and Biophysical Research Communications 2021cited by 19position: middledoi
Long non‑coding RNA AC245100.4 promotes prostate cancer tumorigenesis via the microRNA‑145‑5p/RBBP5 axis
Oncology Reports 2020cited by 30position: middledoi
LncRNA <i>AC245100.4</i> Binds HSP90 to Promote the Proliferation of Prostate Cancer
Epigenomics 2020cited by 24position: middledoi
Influence of the medication environment on the unsafe medication behaviour of nurses: A path analysis
Journal of Clinical Nursing 2018cited by 18position: lastdoi
Prostate cancer cell proliferation is suppressed by microRNA‑3160‑5p via targeting of F‑box and WD repeat domain containing 8
Oncology Letters 2018cited by 12position: firstdoi
Differential expression profiles of long non-coding RNAs as potential biomarkers for the early diagnosis of acute myocardial infarction
Oncotarget 2017cited by 27position: lastdoi
Role of RbBP5 and H3K4me3 in the vicinity of Snail transcription start site during epithelial-mesenchymal transition in prostate cancer cell
Oncotarget 2016cited by 19position: middledoi
OCT4B modulates OCT4A expression as ceRNA in tumor cells
Oncology Reports 2015cited by 55position: middledoi
Hypoxia promotes HO-8910PM ovarian cancer cell invasion via Snail-mediated MT1-MMP upregulation
Experimental Biology and Medicine 2015cited by 15position: middledoi
MicroRNA-124 regulates TGF-α-induced epithelial-mesenchymal transition in human prostate cancer cells
International Journal of Oncology 2014cited by 33position: middledoi
The CUL7/F-box and WD Repeat Domain Containing 8 (CUL7/Fbxw8) Ubiquitin Ligase Promotes Degradation of Hematopoietic Progenitor Kinase 1
Journal of Biological Chemistry 2013cited by 46position: middledoi
Pseudolaric acid B induces apoptosis via proteasome-mediated Bcl-2 degradation in hormone-refractory prostate cancer DU145 cells
Toxicology in Vitro 2012cited by 31position: middledoi
DNA methylation inhibitor, decitabine, promotes MGC803 gastric cancer cell migration and invasion via the upregulation of NEDD4-1
Molecular Medicine Reports 2012cited by 12position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaoguang Yu · Harbin Medical University11 papers (2012–2022)Rongjun Cui · Harbin Medical University6 papers (2012–2020)Hui Xie · University of Iowa5 papers (2020–2022)Chi Liu · Guangzhou University of Chinese Medicine5 papers (2020–2023)Hui Sun · Harbin Medical University4 papers (2012–2018)Jiebing Tang · Harbin Medical University4 papers (2012–2023)Huizhen Jia · Fudan University4 papers (2021–2023)Chunyan Xu · Harbin Medical University3 papers (2012–2015)Zhengkai Yang · Harbin Medical University3 papers (2012–2018)Rou Li · Harbin Medical University3 papers (2021–2022)Jingyi Bu · Harbin Medical University3 papers (2012–2015)Ke Zhang · Heidelberg University3 papers (2022–2023)Dong Li · Harbin Medical University3 papers (2015–2018)Xiulan Zheng · Harbin Medical University2 papers (2015–2018)Xiulan Zheng · Harbin Medical University2 papers (2014–2016)Xueqin Gao · Nantong University2 papers (2017–2018)Wenjing Sun · Nanjing University of Chinese Medicine2 papers (2016–2018)Yujia Pan · Sun Yat-sen University Cancer Center2 papers (2014–2016)Jiabin Zhao · Harbin Medical University2 papers (2020–2020)Nan Wang · Weifang Medical University2 papers (2021–2022)